Is your contention that if there is efficacy along with safety they do not report it? If it was not effective would you want to know? If yes, why would you not want to know if it was positive?
The fact that the trial monitored the patients and benefited the patients should be something to celebrate, right? Or because you are a non-holder you don’t care?
I am a non holder but appreciate the info and this Ann had triggered my interest in the company. Apologies that the sentiment was incorrect before and I have corrected it to None, Not held.
Ann: CORE NK Platform Phase 1 Clinical Data Presentation, page-30
Add to My Watchlist
What is My Watchlist?